[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339693-105":59,"doc-detail-339693-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","comprehensive-single-cell-and-bulk-rna-seq-analyses-reveal-a-novel-cd8-t-cell-associated-prognostic-signature-in-ovarian-cancer","Comprehensive single-cell and bulk RNA-seq analyses reveal a novel CD8+ T cell-associated prognostic signature in ovarian cancer","","CD8+ T cells are central to intracellular pathogen control and malignant cell elimination, yet their prognostic value in ovarian carcinoma remains underused. Using univariate Cox regression and LASSO regression with CD8+ T cell markers from scRNA-seq, a novel prognostic model was built and validated in independent cohorts by median risk-score stratification. Low-risk patients show markedly improved outcomes, greater immune-pathway enrichment, increased infiltration of multiple immune cell types, and higher immunotherapy response rates.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/comprehensive-single-cell-and-bulk-rna-seq-analyses-reveal-a-novel-cd8-t-cell-associated-prognostic-signature-in-ovarian-cancer/339693/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/comprehensive-single-cell-and-bulk-rna-seq-analyses-reveal-a-novel-cd8-t-cell-associated-prognostic-signature-in-ovarian-cancer/339693.png","ImageObject",300,407,{"name":92,"@type":93},"Noah","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main goal of the study for ovarian cancer?","Question",{"text":112,"@type":113},"To develop a novel prognostic model for ovarian carcinoma based on CD8+ T cell markers identified through single-cell RNA sequencing, and to evaluate its prognostic and immunotherapy relevance.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the prognostic model constructed and evaluated?",{"text":117,"@type":113},"The study used univariate Cox regression and LASSO regression to build the model from CD8+ T cell markers derived from scRNA-seq. Patients were then grouped by median risk score to assess prognostic performance in training and validation cohorts.",{"name":119,"@type":110,"acceptedAnswer":120},"What distinguishes low-risk versus high-risk patients in the results?",{"text":121,"@type":113},"Low-risk patients had dramatically improved prognosis, higher enrichment of immune-related pathways, increased infiltration of multiple immune cell types, and a higher response rate to immunotherapies.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},339693,1790167941,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095462418,"https://ap-avatar.wpscdn.com/avatar/80000253c1241d02b47?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778826106357471780","[www.aging-us.com](www.aging-us.com) AGING 2024, Vol. 16, No. 12  \nResearch Paper  \nComprehensive single-cell and bulk RNA-seq analyses reveal a novel CD8+ T cell-associated prognostic signature in ovarian cancer  \nYi-Ling Han1,*, Zhou Fang2,*, Zhi-Jie Gao2,*, Wen-Ge Li3, Jing Yang1  \n1Center for Reproductive Medicine, Renmin Hospital of Wuhan University, Wuhan, China 2 Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, China 3 Department of Oncology, Shanghai Artemed Hospital, Shanghai, China  \n*Equal contribution  \nCorrespondence to: Wen-Ge Li, Jing Yang; email: [2012302180081@whu.edu.cn](2012302180081@whu.edu.cn), [dryangjing@whu.edu.cn](dryangjing@whu.edu.cn)[ ](dryangjing@whu.edu.cn)[Keywords:](Keywords: ovarian carcinoma)[ ovarian carcinoma](Keywords: ovarian carcinoma), CD8+ T cells, scRNA-seq  \nReceived: November 29, 2023 Accepted: May 3, 2024 Published: June 25, 2024  \nCopyright: © 2024 Han et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nABSTRACT  \nCD8+ T cells play pivotal roles in combating intracellular pathogens and eliminating malignant cells in cancer. However, the prognostic role of CD8+ T cells in ovarian carcinoma is insufficiently exploited. Herein, through univariate Cox regression along with least absolute shrinkage and selection operator (LASSO) regression analyses, we developed a novel prognostic model based on CD8+ T cell markers identified by single-cell sequencing (scRNA-seq) analyses. Patient grouping by the median risk score reveals an excellent prognostic efficacy of this model in both training and validation cohorts. Of note, patients classified as low-risk group exhibit a dramatically improved prognosis. In addition, higher enrichment level of immune-related pathways and increased infiltration level of multiple immune cells are found in patients with lower risk score. Importantly, low-risk patients also exhibited higher response rate to immunotherapies. Summarily, this developed CD8+ T cell-associated prognostic model serves as an excellent predictor for clinical outcomes and aids in guiding therapeutic strategy choices for ovarian cancer patients.  \nINTRODUCTION  \nOvarian cancer has the worst prognosis and highest mortality rate among gynecological malignancies worldwide, and is usually diagnosed in advanced stages [1] . Historically, ovarian cancer was consistently treated without considering the distinct biological features among patients, and this trend continues to prevail. In recent years, with increasing recognition of tumor heterogeneity, accumulating studies have emphasized the importance of adopting a standardized and molecular marker-based approach for accurately categorizing ovarian cancers [2] . However, the lack of current powerfully efficient biomarkers and prognostic signatures for ovarian cancer is primarily responsible for the poor prognosis. In summary, the limited treatment efficacy and unfavorable outcomes of ovarian cancer patients make it particularly urgent  \nto develop a novel prognostic signature and guide individual treatment plans for ovarian cancer.  \nThe tumor microenvironment (TME) acts as a complex ecosystem consisting of malignant cells, diverse infiltrating immune cells (lymphocytes and myeloid cells), and stromal cells intertwined with non-cellular components. Tumor-infiltrating T cells are critical players in the TME and influence essential clinical properties, such as cancer immunotherapy responses, with a particular significance for CD8+ T cells. The association between the infiltration of T cells in cancer lesions and improved patient prognosis has been widely recognized in various human malignancies for a significant period of time. For example, in human melanoma, the presence of abundant T cell infiltrates has","cbCaivk08xlgRGIC","https://ap.wps.com/l/cbCaivk08xlgRGIC","pdf",4240885,21,"English","# ABSTRACT\n# INTRODUCTION","[{\"question\":\"What was the main goal of the study for ovarian cancer?\",\"answer\":\"To develop a novel prognostic model for ovarian carcinoma based on CD8+ T cell markers identified through single-cell RNA sequencing, and to evaluate its prognostic and immunotherapy relevance.\"},{\"question\":\"How was the prognostic model constructed and evaluated?\",\"answer\":\"The study used univariate Cox regression and LASSO regression to build the model from CD8+ T cell markers derived from scRNA-seq. Patients were then grouped by median risk score to assess prognostic performance in training and validation cohorts.\"},{\"question\":\"What distinguishes low-risk versus high-risk patients in the results?\",\"answer\":\"Low-risk patients had dramatically improved prognosis, higher enrichment of immune-related pathways, increased infiltration of multiple immune cell types, and a higher response rate to immunotherapies.\"}]","Comprehensive single-cell and bulk RNA-seq analyses reveal a novel CD8+ T cell-associated prognostic signature in ovarian cancer | PDF",1790031639,53,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/89ddee1626b0094619ac8a58bc25ed01.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0e48692dac5991aa32f08adbe4d35d80.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fe8e06c5743a822381894037b1c30ec4.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2d75310d9dda64ce5bb6a6bd0c72a2e4.webp",980,1268]